Skip to main content

Steve Lombardi, Craig Rine, Michael Angarita, Michael Morgan, Premier Biosoft International

Premium

People in the News

Steve Lombardi has joined Helicos BioSciences as senior vice president of marketing.

Lombardi most recently served as a senior vice president at Affymetrix, where he was responsible for corporate development, product R&D and marketing, and corporate marketing between 2002 and 2006.

Prior to Affymetrix, Lombardi worked for 16 years at Applied Biosystems as a marketing manager and as an executive. From 1989 to 1998, Lombardi managed ABI's DNA sequencing and genetic analysis business.


Arizona-based array firm HTG this week announced the addition of two new national account managers to its sales force.

Craig Rine will be responsible for accounts in the northeastern US, HTG said. Rine previously served as drug discovery manager of Invitrogen. He also served as the director of US sales at MesoScale Discovery and director of the academic market segment at PerkinElmer Life Sciences.

Michael Angarita will handle accounts in the Midwestern US. Angarita comes to HTG from Telechem International where he was director of sales. Angarita has previously worked for Mergen, Transgenomic, LKH Imaging, American Bionetics, and Pharmacia.


Genome Canada has appointed Michael Morgan as chief scientific officer.

Morgan was formerly chief executive of the Wellcome Trust Genome Campus. He graduated in biochemistry from Trinity College, Dublin, and obtained his PhD from Leicester University for studies of microbial carbohydrate metabolism. He joined the Wellcome Trust in 1983.

At the Wellcome Trust, Morgan was responsible for the development of several initiatives, including the International Human Genome Sequencing Project, the Mouse Sequencing Project, the UK Synchrotron, DIAMOND, the SNP Consortium, and the Structural Genomics Consortium.

 

New Product Watch

Premier Biosoft International last week launched AlleleID version 3, a tool for designing oligonucleotides for use in both RT-PCR and microarray-based pathogen identification assays.

AlleleID is capable of aligning sequences and analyzes conserved and species- specific regions to design molecular probes for microarrays and TaqMan molecular beacon RT-PCR assays, according to Premier.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.